Serbia to invest in antenatal genetic testing:
This article was originally published in Clinica
Executive Summary
Serbia has earmarked over E2m ($2.6m) for the procurement of diagnostic equipment for detecting genetic abnormalities in the early stages of pregnancy. This follows a donation to the country of E2.5m by the European Agency for Reconstruction (EAR). Current capacities for diagnosing abnormalities antenally meet only one-third of needs, according to Matthias Reinicke, programme manager at EAR. The remaining funding will be used for training.